摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

哌氧平 | 14008-66-3

中文名称
哌氧平
中文别名
哌诺平
英文名称
Pinoxepin
英文别名
2-[4-[(3Z)-3-(2-chloro-6H-benzo[c][1]benzoxepin-11-ylidene)propyl]piperazin-1-yl]ethanol
哌氧平化学式
CAS
14008-66-3
化学式
C23H27ClN2O2
mdl
——
分子量
398.9
InChiKey
RAAHIUIRJUOMAU-MPUCSWFWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    28
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.39
  • 拓扑面积:
    35.9
  • 氢给体数:
    1
  • 氢受体数:
    4

文献信息

  • Co-administration of dopamine-receptor binding compounds
    申请人:Fernandes B. Prabhavathi
    公开号:US20070155720A1
    公开(公告)日:2007-07-05
    Methods for treating a patient having neurological, psychotic, and psychiatric disorders are described comprising the steps of administering to the patient an effective amount of a partial and/or full dopamine D 1 receptor agonist, and administering to the patient an effective amount of a dopamine D 2 receptor antagonist. Pharmaceutical compositions comprising a dopamine D 1 receptor agonist and a dopamine D 2 receptor antagonist are also described. The D 1 dopamine receptor agonist and the D 2 dopamine receptor antagonist can be administered to the patient in the same or in a different composition or compositions.
    描述了治疗患有神经、精神和精神障碍的患者的方法,包括向患者施用部分和/或全多巴胺D1受体激动剂的有效量,并向患者施用多巴胺D2受体拮抗剂的有效量。还描述了包含多巴胺D1受体激动剂和多巴胺D2受体拮抗剂的药物组合物。D1多巴胺受体激动剂和D2多巴胺受体拮抗剂可以以相同或不同的组合或组合物形式向患者施用。
  • [EN] CARBONATE PRODRUGS AND METHODS OF USING THE SAME<br/>[FR] PROMÉDICAMENTS CARBONATÉS ET LEURS MÉTHODES D'UTILISATION
    申请人:NEUROGESX INC
    公开号:WO2009143297A1
    公开(公告)日:2009-11-26
    The present invention provides carbonate prodrugs which comprise a carbonic phosphoric anhydride prodrug moiety attached to the hydroxyl or carboxyl group of a parent drug moiety. The prodrugs may provide improved physicochemical properties over the parent drug. Also provided are methods of treating a disease or condition that is responsive to the parent drug using the carbonate prodrugs, as well as kits and unit dosages.
    本发明提供了碳酸盐前药,其包括连接到母药基团的羟基或羧基上的碳酸磷酸酐前药基团。这些前药可能比母药具有改进的物理化学性质。还提供了使用碳酸盐前药治疗对母药具有响应的疾病或症状的方法,以及配套工具和单剂量。
  • [EN] PRODRUG COMPOSITIONS AND METHODS OF TREATMENT<br/>[FR] COMPOSITIONS DE PROMÉDICAMENT ET PROCÉDÉS DE TRAITEMENT
    申请人:AQUESTIVE THERAPEUTICS INC
    公开号:WO2021087359A1
    公开(公告)日:2021-05-06
    Pharmaceutical compositions include a prodrug of epinephrine are described.
    药物组合物包括表述的肾上腺素前药。
  • Multi-functional ionic liquid compositions for overcoming polymorphism and imparting improved properties for active pharmaceutical, biological, nutritional, and energetic ingredients
    申请人:Rogers D. Robin
    公开号:US20070093462A1
    公开(公告)日:2007-04-26
    Disclosed are ionic liquids and methods of preparing ionic liquid compositions of active pharmaceutical, biological, nutritional, and energetic ingredients. Also disclosed are methods of using the compositions described herein to overcome polymorphism, overcome solubility and delivery problems, to control release rates, add functionality, enhance efficacy (synergy), and improve ease of use and manufacture.
    揭示了离子液体及制备活性药物、生物、营养和能量成分的离子液体组合物的方法。还揭示了利用本文描述的组合物的方法,以克服多型性、克服溶解度和输送问题、控制释放速率、增加功能性、增强功效(协同作用)以及改善易用性和制造工艺。
  • [EN] DREADD ACTUATORS<br/>[FR] ACTIONNEURS DREADD
    申请人:US HEALTH
    公开号:WO2019157083A1
    公开(公告)日:2019-08-15
    Disclosed is a compound of formula (I) in which R1, R2, and R3 are as described herein. Also provided are pharmaceutical compositions comprising the compound of formula (I) and methods of using the compound of formula (I), including a method of treating a disease or disorder and a method for effectuating a G-protein coupled receptor (GPCR)-mediated response in a subject.
    公开了一种化合物的化学式(I),其中R1、R2和R3如本文所述。还提供了包含化合物的药物组合物的制剂(I)和使用化合物的方法(I),包括治疗疾病或紊乱的方法以及在受试者中实现G蛋白偶联受体(GPCR)介导的反应的方法。
查看更多